US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

GNPX

Genprex (GNPX)

Genprex Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNPX

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
20/12/2024	07:45	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GNPX	Genprex Inc
16/12/2024	08:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GNPX	Genprex Inc
16/12/2024	08:15	PR Newswire (US)	Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer	NASDAQ:GNPX	Genprex Inc
06/12/2024	16:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNPX	Genprex Inc
20/11/2024	08:29	PR Newswire (US)	Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer	NASDAQ:GNPX	Genprex Inc
13/11/2024	08:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GNPX	Genprex Inc
05/11/2024	08:29	PR Newswire (US)	Genprex Collaborators Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting	NASDAQ:GNPX	Genprex Inc
31/10/2024	08:29	PR Newswire (US)	Genprex to Participate in 2024 BIO Europe Conference	NASDAQ:GNPX	Genprex Inc
28/10/2024	08:29	PR Newswire (US)	Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma	NASDAQ:GNPX	Genprex Inc
24/10/2024	11:23	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:GNPX	Genprex Inc
24/10/2024	08:29	PR Newswire (US)	Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive	NASDAQ:GNPX	Genprex Inc
22/10/2024	11:01	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:GNPX	Genprex Inc
15/10/2024	08:29	PR Newswire (US)	Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer	NASDAQ:GNPX	Genprex Inc
10/10/2024	08:29	PR Newswire (US)	Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics	NASDAQ:GNPX	Genprex Inc
07/10/2024	08:29	PR Newswire (US)	Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting	NASDAQ:GNPX	Genprex Inc
23/09/2024	08:29	PR Newswire (US)	Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes	NASDAQ:GNPX	Genprex Inc
19/09/2024	08:29	PR Newswire (US)	Genprex Announces Formation of Mesothelioma Clinical Advisory Board	NASDAQ:GNPX	Genprex Inc
04/09/2024	08:29	PR Newswire (US)	Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes	NASDAQ:GNPX	Genprex Inc
03/09/2024	07:15	PR Newswire (US)	Genprex to Present and Participate at Upcoming September Investor and Industry Conferences	NASDAQ:GNPX	Genprex Inc
15/08/2024	08:30	PR Newswire (US)	Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials	NASDAQ:GNPX	Genprex Inc
14/08/2024	08:25	PR Newswire (US)	Genprex Announces Positive Clinical Study Updates from Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials in Lung Cancer	NASDAQ:GNPX	Genprex Inc
13/08/2024	07:31	PR Newswire (US)	Genprex Granted Patent in Singapore for Reqorsa® Gene Therapy with PD-1 Antibodies to Treat Cancers	NASDAQ:GNPX	Genprex Inc
08/08/2024	07:30	PR Newswire (US)	Genprex to Present at the August Sidoti Microcap Conference	NASDAQ:GNPX	Genprex Inc
27/06/2024	07:31	PR Newswire (US)	Genprex Issues Stockholder Letter and Provides 2024 Corporate Update	NASDAQ:GNPX	Genprex Inc
30/05/2024	07:31	PR Newswire (US)	Genprex to Present at the 2024 BIO International Convention	NASDAQ:GNPX	Genprex Inc
14/05/2024	07:31	PR Newswire (US)	Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer	NASDAQ:GNPX	Genprex Inc
13/05/2024	07:31	PR Newswire (US)	Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors	NASDAQ:GNPX	Genprex Inc
08/05/2024	17:08	PR Newswire (US)	Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner	NASDAQ:GNPX	Genprex Inc
01/05/2024	07:31	PR Newswire (US)	Genprex to Present and Participate at Upcoming May Investor and Industry Conferences	NASDAQ:GNPX	Genprex Inc
09/04/2024	07:31	PR Newswire (US)	Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting	NASDAQ:GNPX	Genprex Inc

Showing the most relevant articles for your search:NASDAQ:GNPX

1 2 3 4 5 6 7 8 9 10 Próxima >

JP Morgan Chase

Bank of America

Financial Select Sector

Deutsche Telekom (QX)

American Express

Gold vs US Dollar

US Dollar vs MXN

Health Care Select Sector

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones